Skip to content

Evaluation of 3D Visualization for Total Colectomy

Comparative Assessment of Three-dimensional vs. Conventional Laparoscopy in a Total Colectomy Model for Ulcerative Colitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02370056
Acronym
3Dvs2DforUC
Enrollment
53
Registered
2015-02-24
Start date
2015-03-31
Completion date
2019-05-17
Last updated
2021-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Brief summary

The anticipated advantages of 3D laparoscopic visualization for the surgeon are greater accuracy and speed in manual skills, translating to decreased operative time, reduced learning curve, and superior safety.We aimed to determine the feasibility of the laparoscopic approach using 3D visualization in the surgical treatment of ulcerative colitis

Detailed description

Three-dimensional (3D) visualization technology for laparoscopy has been proposed, since the early 1990's, as a method to facilitate laparoscopic performance. However, early 3D laparoscopic technology was limited in terms of image quality, so that its use had not been implemented. The latest technical developments ensure high-definition 3D visualization with the same quality that current two-dimensional (2D) systems provide. The anticipated advantages of 3D laparoscopic visualization for the surgeon are greater accuracy and speed in manual skills, translating to decreased operative time, reduced learning curve, and superior safety . It was reported that, 3D laparoscopic visualization offers significant advantages in enhancing laparoscopic performance, even in novice surgeons, comparing to the 2D systems . We hypothesize that 3D visualization may allow surgeons to reduce the overall operating time with a rate of 10% with comparable perioperative and postoperative outcomes. The primary endpoint of this study is to determine the feasibility of the laparoscopic approach using 3D visualization in the surgical treatment of ulcerative colitis. Secondary endpoints are to determine whether 3D visualization confers benefits such as reduced operating time and intra-operative complications with comparable postoperative outcomes. Device Description: The EXERA III Universal Platform will be used in this study, in conjunction with the ENDOEYE FLEX 3D. The ENDOEYE FLEX 3D can also be used in 2D mode, by utilizing a programmed button on the handle of the scope, or by using the 2D/3D button on the 3D Visualization Unit. The articulating tip of the ENDOEYE FLEX allows for the scope to be used in both single-site and multi-port procedures, providing critical views and allowing a bird's eye view so that the scope is out of the way of other instruments (while still capturing the image at the surgical site). All equipment used in this trial has been cleared under 510(k) approval by the FDA, and has been on the market in the US since April 2013. The Olympus HD 3D Laparoscopic Surgical Video System consists of the following components: * CV-190 Processor * CLV-190 Light Source * 3DV-190 3D Visualization Unit * LMD-2451MT/3G4 Sony 24 3D Monitor * IMH-20 Image Capture System * UHI-4 Insufflator * K10021611 Cart * OL-0015-08 Tall Rollstand * LTF-190-10-3D ENDOEYE FLEX 3D Videoscope * 3D glasses (regular and clip-on styles) Study Size:Mean operating time for laparoscopic subtotal colectomy for medically refractory UC was reported longer with a comparison to open surgery in the recently published studies. Therefore the effort to decrease operating time in laparoscopic colectomy has gained importance. We assumed that, in order to be able to determine a 10% reduction in mean operating time, each group should include 27 patients (80% power and 5% significance). Patients who will undergo laparoscopic total abdominal colectomy (TAC) for UC will be included in the study. All subjects will be randomized into two groups: 3D laparoscopy, and 2D laparoscopy. Three staff surgeons (EG, HK, FR) at the department of colorectal surgery, Cleveland Clinic, Ohio will perform the procedures with 2D and 3D laparoscopy. Each surgeon will perform 9 total colectomies with 3D, and 9 total colectomies with the 2D laparoscopy system. In total, 54 patients will be included (27 patients for each group).

Interventions

DIAGNOSTIC_TEST3-dimensional visualization

Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode

DIAGNOSTIC_TEST2-dimensional visualization

Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Indication for surgery must be Ulcerative Colitis * Patient age between 18 and 80 * Elective procedure * BMI between 17 and 30 * Total colectomy with end ileostomy, without proctectomy

Exclusion criteria

* Any preoperative diagnosis other than UC * Patient age\< 18, or \>80 * Emergency surgery * Previous gastrointestinal surgery * BMI\>30 * Pregnancy * Presence of any gastrointestinal tract malignancy * Segmental colon resections, completion proctectomy, total proctocolectomy, pouch procedures

Design outcomes

Primary

MeasureTime frameDescription
Operating Time180 minutestotal operating time

Secondary

MeasureTime frameDescription
Major Complication180 minutesNumber of Participants with Intraoperative Complications

Countries

United States

Participant flow

Participants by arm

ArmCount
3D Visualization
3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System. This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated. 3-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode
27
2D Visualization
2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System. This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated. 2-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode
26
Total53

Baseline characteristics

Characteristic3D Visualization2D VisualizationTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants5 Participants7 Participants
Age, Categorical
Between 18 and 65 years
25 Participants21 Participants46 Participants
Age, Continuous36.8 years
STANDARD_DEVIATION 15.2
43.2 years
STANDARD_DEVIATION 17
40.0 years
STANDARD_DEVIATION 16.3
Average BMI23.0 kg/m^2
STANDARD_DEVIATION 4.25
23.9 kg/m^2
STANDARD_DEVIATION 5.17
23.5 kg/m^2
STANDARD_DEVIATION 4.72
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
27 participants26 participants53 participants
Sex: Female, Male
Female
11 Participants12 Participants23 Participants
Sex: Female, Male
Male
16 Participants14 Participants30 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 270 / 26
other
Total, other adverse events
0 / 270 / 26
serious
Total, serious adverse events
8 / 277 / 26

Outcome results

Primary

Operating Time

total operating time

Time frame: 180 minutes

ArmMeasureValue (MEAN)Dispersion
3D VisualizationOperating Time75.3 minutesStandard Deviation 30.8
2D VisualizationOperating Time82.7 minutesStandard Deviation 38.6
Secondary

Major Complication

Number of Participants with Intraoperative Complications

Time frame: 180 minutes

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
3D VisualizationMajor Complication8 Participants
2D VisualizationMajor Complication8 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026